ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.

Written by Ben

August 28, 2018

SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced key upgrades to its Astral life support ventilators, including Optional AutoEPAP in iVAPS for U.S. patients, a high-demand therapy option.

AutoEPAP now available for U.S. Astral ventilator users, plus worldwide upgrades for ease of use and peace of mind. #respiratorycare

Tweet this

What is AutoEPAP?

AutoEPAP (automatic expiratory positive airway pressure) automatically adjusts a patient’s expiratory pressure in response to flow limitations or obstruction of the upper airway.

AutoEPAP is now available in the United States, and already in use in other markets. It’s an option when in Astral’s iVAPS (intelligent Volume-Assured Pressure Support) mode that automatically adapts to a patient’s changing pressure needs as their respiratory disease progresses.

Other upgrades

In addition to AutoEPAP, Astral users worldwide can now:

  • Easily change interfaces: Patients can easily change between a mouthpiece and a full face, nasal or pillows mask from a single limb circuit.
  • Customize program names: Clinicians can now name programs on a patient’s Astral device for fast, easy access.

“These significant upgrades make Astral one of the most advanced life support ventilators on the market,” said Richie McHale, president of ResMed’s Respiratory Care business. “It’s already proven to stabilize ventilation in significantly fewer breaths than its leading competitor,1 and today’s innovations offer greater ease of use and even more peace of mind to patients across a wide range of respiratory diseases than ever before.”

About ResMed

ResMed (NYSE: RMD) (ASX: RMD), a world-leading connected health company with more than 5 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com

Diesem Ryan. Astral/Trilogy iVAPS/AVAPS Comparison. Valley Inspired Products 2016; 16011.

Related Articles

ESA, NASA Solar Observatory Discovers Its 5,000th Comet

ESA, NASA Solar Observatory Discovers Its 5,000th Comet

On March 25, 2024, a citizen scientist in the Czech Republic spotted a comet in an image from the Solar and Heliospheric Observatory (SOHO) spacecraft, which has now been confirmed to be the 5,000th comet discovered using SOHO data. SOHO has achieved this...

IXPE Operations Update

IXPE Operations Update

On March 23, NASA’s IXPE (Imaging X-ray Polarimetry Explorer) stopped transmitting valid telemetry data. The only previous interruption of IXPE science observations was due to a similar issue in June of 2023. On March 26, using procedures developed following...

Gibson Celebrates 130 Years of Craft, Innovation, and Music

Gibson Celebrates 130 Years of Craft, Innovation, and Music

Gibson has been shaping the sound of music since 1894, when Orville Gibson designed and built his earliest-known musical instrument in his workshop in Kalamazoo, Michigan. 130 years later, you can still play it and it sounds better than ever....

Check out our Amazon Store

Lookin in our Amazon Store and pick up the items we review and talk about (if you purchase something from our store, we earn a small comission)

Join Our Newsletter

Click below and never miss a thing